Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Acne Treatment with Birth Control and Spironolactone

Safety and Efficacy

  • The American Academy of Dermatology suggests that spironolactone appears safe in patients receiving concomitant therapy with a drospirenone-containing combined oral contraceptive without increased risk of hyperkalemia 1, 2
  • In a study of women with acne treated with both a COC containing drospirenone and spironolactone, no significant elevations of serum potassium were found, and there were no additional side effects significant enough to discontinue treatment 3
  • COCs containing estrogen and progestin address the hormonal pathogenesis of acne by decreasing free testosterone by 40-50% on average 1
  • Spironolactone works as an aldosterone receptor antagonist with potent anti-androgenic activity, decreasing testosterone production and inhibiting binding of testosterone to androgen receptors in the skin 3, 4

Practical Considerations and Monitoring

  • The American Academy of Dermatology recommends concomitant use of a COC to regulate menses in women taking spironolactone, as it can cause menstrual irregularities in 22% of users 3
  • Spironolactone is pregnancy category C and can cause feminization of a male fetus, making contraception important for women taking this medication 2, 3
  • Potassium monitoring in young, healthy women on spironolactone is not required unless they have specific risk factors for hyperkalemia 1, 2
  • A thorough medical history and blood pressure measurement are important before prescribing a COC 5

Contraindications and Special Considerations

  • COCs with drospirenone carry a slightly higher risk of venous thromboembolism compared to other COCs 1
  • The labeling for drospirenone-containing COCs includes a warning to limit use to those who also desire a COC for birth control due to thromboembolism risk 1